No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
BSX250117C75000
- 20.50
- +0.91+4.65%
15min DelayClose Jan 14 16:00 ET
20.50High20.50Low
20.50Open19.59Pre Close1 Volume1.81K Open Interest75.00Strike Price2.05KTurnover187.10%IV-0.16%PremiumJan 17, 2025Expiry Date20.65Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9454Delta0.0072Gamma4.54Leverage Ratio-0.2743Theta0.0051Rho4.29Eff Leverage0.0090Vega
Intraday
- 5D
- Daily
News
CardioFocus Announces Publication of 1-Year ECLIPSE AF Clinical Trial Results
Boston Scientific Expects Farapulse, Watchman to Drive 2025 Growth
Citi Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $107
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors
Why Boston Scientific (BSX) Is Skyrocketing in 2025?
Baird Adjusts Price Target on Boston Scientific $104 From $102, Keeps Outperform Rating